All practice questions

Question 3741Question →

A 38-year-old woman is evaluated in the clinic for progressive weight gain, severe proximal muscle weakness, and easy bruising over the past 14 months. Blood pressure is 158/98 mm Hg. Physical examination reveals pronounced central adiposity, facial plethora, and wide, violaceous abdominal striae. Basic laboratory testing shows a fasting blood glucose of 145 mg/dL. The physician suspects Cushing syndrome and plans a comprehensive biochemical diagnostic workup.

Arrange the following diagnostic tests in the most appropriate sequential order to establish the diagnosis and etiology of this patient's condition, starting with the initial screening step and concluding with the definitive invasive localization test.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with establishing the presence of hypercortisolism (24-hour urine free cortisol), followed by determining ACTH dependence (Plasma ACTH), differentiating the source of ACTH (High-dose dexamethasone suppression test), and finally confirming the pituitary source definitively (Inferior petrosal sinus sampling).

The diagnostic evaluation of Cushing syndrome strictly follows a step-wise physiological logic to minimize false positives and avoid unnecessary invasive procedures. The correct sequence is: 1) Establish hypercortisolism (24-hour urine free cortisol) to confirm the disease state. 2) Determine ACTH-dependence (Plasma ACTH) to separate adrenal (ACTH-independent) from central/ectopic (ACTH-dependent) etiologies. 3) Differentiate the ACTH source non-invasively (High-dose dexamethasone suppression test), as pituitary sources typically suppress while ectopic sources do not. 4) Perform invasive localization (Inferior petrosal sinus sampling) only when non-invasive tests and imaging fail to clearly identify the source.

Step-by-Step Solution

1

Select the initial screening test for hypercortisolism.

24-hour urine free cortisol excretion.

Before localizing a lesion, biochemical evidence of pathological hypercortisolism must be definitively established using 24-hour urine free cortisol, late-night salivary cortisol, or a 1-mg overnight dexamethasone suppression test.

2

Select the test to categorize the hypercortisolism.

Plasma adrenocorticotropic hormone (ACTH) concentration.

A suppressed ACTH level indicates an ACTH-independent adrenal source, while a normal or elevated ACTH level indicates an ACTH-dependent source (pituitary or ectopic).

3

Select the non-invasive test to differentiate ACTH-dependent sources.

High-dose (8-mg) dexamethasone suppression test.

Pituitary adenomas causing Cushing disease typically retain some negative feedback sensitivity and will suppress cortisol production with high-dose dexamethasone, whereas ectopic ACTH tumors do not.

4

Select the definitive localization test for challenging cases.

Inferior petrosal sinus sampling (IPSS).

If non-invasive biochemical tests and MRI are equivocal or discordant, IPSS is used to measure the central-to-peripheral ACTH gradient to definitively confirm or rule out a pituitary source.

Key Concept

Diagnostic algorithm and test sequencing for Cushing syndrome.

Estimated Time:1m 30s

Question 3742Question →

Pair the following isolated pharmacokinetic alterations with their direct mathematical implication on therapeutic drug dosing and plasma concentration.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Increases in volume of distribution necessitate higher loading doses, decreases in clearance necessitate lower maintenance doses, enzyme saturation causes non-linear drug accumulation, and proportional decreases in both bioavailability and clearance leave steady-state concentrations unchanged.

Each pharmacokinetic alteration mathematically dictates a specific clinical outcome based on standard PK formulas.

V_d

determines the compartment size to fill (Loading Dose),

CL

determines the rate of drug removal to replace (Maintenance Dose), first-order to zero-order shifts remove linear predictability, and

F/CL

ratios determine the net steady state.

Step-by-Step Solution

1

Evaluate the mathematical formula for Loading Dose (

LD

).

LD = (C_{target} \times V_d) / F

.

This shows that

LD

is directly proportional to

V_d

and independent of clearance (

CL

).

2

Evaluate the mathematical formula for Maintenance Dose (

MD

).

MD = (C_{ss} \times CL \times \tau) / F

.

This confirms that

MD

is directly proportional to

CL

and independent of

V_d

.

3

Analyze the impact of zero-order kinetics on drug accumulation.

Elimination rate becomes constant (e.g.,

10

mg/hr) rather than proportional to concentration.

Because elimination cannot scale up as drug levels rise, small dose increases cause disproportionate, non-linear spikes in plasma concentration.

4

Calculate the net effect of simultaneous changes to bioavailability (

F

) and clearance (

CL

) on steady-state concentration (

C_{ss}

).

Since

C_{ss}

is proportional to

F/CL

, a

50\%

decrease in both leaves the fraction mathematically unchanged (e.g.,

0.5F / 0.5CL = F/CL

).

Understanding the algebraic relationship prevents unnecessary dose adjustments when paired pharmacokinetic parameters cancel each other out.

Key Concept

The core relationships between pharmacokinetic parameters (

V_d

,

CL

,

F

) and clinical dosing equations (loading dose, maintenance dose, and steady-state concentration).

Question 3743Question →

A 52-year-old woman comes to the clinic for follow-up of hypertension and new-onset muscle cramps. Her blood pressure was previously well-controlled on amlodipine and lisinopril, but over the past two months, it has consistently been above 160/100 mmHg. Today, her blood pressure is 168/104 mmHg and her heart rate is 76/min. Laboratory results show:

Sodium: 144 mEq/L
Potassium: 2.7 mEq/L
Bicarbonate: 31 mEq/L
Creatinine: 0.9 mg/dL

Subsequent endocrinologic evaluation reveals profoundly suppressed plasma renin activity and undetectable serum aldosterone levels. The patient reports absolute adherence to her prescribed antihypertensive regimen and denies illicit drug use. She mentions that she recently adopted a "natural" holistic lifestyle to help manage occasional indigestion and promote weight loss. To ascertain the etiology of this patient's current clinical and laboratory findings, the physician should specifically question the patient about her daily consumption of which of the following?

Over-the-counter nonsteroidal anti-inflammatory drugs

Grapefruit juice and related citrus beverages

Licorice-containing herbal products

St. John's wort extracts

Ephedra-based weight loss supplements

Show answer & explanation

Answer: Licorice-containing herbal products

Answer

Licorice-containing herbal products

The correct answer identifies licorice-containing herbal products because licorice root contains glycyrrhizin, which inhibits the enzyme 11-beta-hydroxysteroid dehydrogenase type 2. This inhibition prevents the conversion of cortisol to cortisone, allowing cortisol to chronically bind to and activate mineralocorticoid receptors in the kidney. This produces a syndrome of apparent mineralocorticoid excess characterized by hypertension, hypokalemia, metabolic alkalosis, and suppressed renin and aldosterone levels. Given the patient's new-onset symptoms and her history of adopting a holistic lifestyle to manage indigestion (a common reason for using licorice), inquiring about licorice consumption is the critical next step in her medical history evaluation.

Step-by-Step Solution

1

Analyze the patient's laboratory and clinical findings.

The patient has resistant hypertension, severe hypokalemia, metabolic alkalosis, and suppressed renin and aldosterone levels.

Identifying this specific constellation of findings narrows the differential diagnosis to the syndrome of apparent mineralocorticoid excess or exogenous mineralocorticoid administration.

2

Correlate the syndrome of apparent mineralocorticoid excess with the patient's recent history.

The patient recently started a "natural" lifestyle for indigestion, which strongly suggests the ingestion of licorice root.

Licorice contains glycyrrhizic acid, a known inhibitor of 11-beta-hydroxysteroid dehydrogenase type 2, which perfectly explains all her symptoms.

3

Determine the most appropriate historical element to evaluate.

Question the patient about her daily consumption of licorice-containing herbal products.

Eliciting this specific dietary history confirms the diagnosis and avoids unnecessary and invasive diagnostic workups.

Key Concept

Patients presenting with resistant hypertension, hypokalemia, metabolic alkalosis, and suppressed renin and aldosterone should be carefully evaluated for the ingestion of licorice root. Glycyrrhizin in licorice inhibits 11-beta-hydroxysteroid dehydrogenase type 2, causing apparent mineralocorticoid excess.

Question 3744Question →

A 74-year-old woman is brought to the emergency department by her son due to the sudden onset of agonizing abdominal pain that started two hours ago. She has a medical history of hypertension, hyperlipidemia, and paroxysmal atrial fibrillation. She stopped taking her prescribed apixaban three weeks ago due to financial difficulties. Her temperature is $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ ), blood pressure is $155/90 \text{ mmHg}$ , heart rate is $118/\text{min}$ and irregularly irregular, and respiratory rate is $22/\text{min}$ . She appears in extreme distress, continuously writhing and unable to find a comfortable position on the stretcher. Abdominal examination reveals a flat, non-distended contour. Bowel sounds are hypoactive. The abdomen is completely soft and exhibits only mild, diffuse tenderness to deep palpation. There is absolutely no guarding, rigidity, rebound tenderness, or palpable organomegaly. Digital rectal examination shows normal sphincter tone and brown, Guaiac-negative stool. Laboratory studies demonstrate a leukocyte count of $16,500/\text{mm}^3$ and a serum lactate level of $3.2 \text{ mmol/L}$ (normal: $0.5-2.2 \text{ mmol/L}$ ). Which of the following is the most likely diagnosis given the striking disparity between this patient's subjective symptoms and her objective physical examination findings?

Embolic occlusion of the superior mesenteric artery

Spontaneous perforation of a duodenal ulcer

Acute inflammation of a colonic diverticulum

Rupture of an abdominal aortic aneurysm

Transient systemic hypoperfusion secondary to tachyarrhythmia

Show answer & explanation

Answer: Embolic occlusion of the superior mesenteric artery

Answer

Embolic occlusion of the superior mesenteric artery

The patient's clinical presentation is classic for acute mesenteric ischemia (AMI), which in this case is likely caused by an embolic occlusion of the superior mesenteric artery due to her un-anticoagulated atrial fibrillation. The quintessential physical examination hallmark of early AMI is severe, agonizing abdominal pain that is entirely out of proportion to the objective abdominal exam findings. Because the visceral peritoneum is poorly innervated and the parietal peritoneum is not yet inflamed, the abdomen typically remains soft and non-tender (or only mildly tender) without guarding, rigidity, or rebound tenderness. The elevated leukocyte count and serum lactate reflect early bowel ischemia, necessitating emergent intervention.

Step-by-Step Solution

1

Analyze the patient's risk factors and history.

The patient has paroxysmal atrial fibrillation and recently discontinued anticoagulation, placing her at very high risk for arterial thromboembolism.

Identifying the pathophysiologic risk factors helps narrow the differential diagnosis for sudden-onset conditions.

2

Evaluate the physical examination findings against the subjective symptoms.

The patient has agonizing, writhing abdominal pain, but her abdomen is soft, non-distended, and lacks peritoneal signs (no guarding, rigidity, or rebound).

This specific discrepancy—pain out of proportion to the physical exam—is the classic clinical hallmark of a specific vascular catastrophe.

3

Interpret the laboratory findings in the context of the physical examination.

The elevated leukocyte count and rising serum lactate indicate early tissue ischemia and necrosis, corroborating a severe underlying ischemic event despite the benign outer abdominal exam.

Lactate elevation in the setting of acute abdominal pain without peritonitis strongly points to bowel ischemia.

4

Synthesize all findings to arrive at the most likely diagnosis.

The combination of atrial fibrillation, sudden severe pain, a benign physical examination, and elevated lactate establishes the diagnosis of acute mesenteric ischemia.

No other diagnosis perfectly accounts for the vascular risk factors, the laboratory abnormalities, and the hallmark physical examination discrepancy.

Key Concept

The hallmark physical examination finding of acute mesenteric ischemia is severe, agonizing abdominal pain that is strikingly out of proportion to a relatively benign, soft, and non-peritonitic abdominal exam.

Alternative Method

While physical examination is the initial key to suspecting this diagnosis, the definitive next step in management would be CT angiography of the abdomen to visualize the arterial occlusion.

Estimated Time:1m 30s

Question 3745Question →

Match the following serum calcium, phosphate, and intact parathyroid hormone (PTH) laboratory profiles to their most appropriate underlying diagnosis. (Reference ranges: Calcium $8.4 - 10.2$ mg/dL, Phosphate $2.7 - 4.5$ mg/dL, Intact PTH $15 - 65$ pg/mL)

Click a left item, then click its matching right item

Show answer & explanation

Answer

Profile 1 matches Primary hyperparathyroidism; Profile 2 matches Secondary hyperparathyroidism (chronic kidney disease); Profile 3 matches Hypoparathyroidism; Profile 4 matches Severe vitamin D deficiency (Osteomalacia).

The correct matches require systematic evaluation of calcium and phosphate in the context of the PTH response. Primary parathyroid overactivity directly causes hypercalcemia and hypophosphatemia. Renal failure causes phosphate retention and poor calcitriol synthesis, leading to hypocalcemia and a compensatory rise in PTH. Primary parathyroid failure drops PTH, causing both hypocalcemia and hyperphosphatemia. Vitamin D deficiency causes poor absorption of both calcium and phosphate, driving PTH up, which further depletes phosphate.

Step-by-Step Solution

1

Evaluate the first profile (Calcium: 11.2, Phosphate: 2.1, PTH: 120).

The patient has hypercalcemia, hypophosphatemia, and elevated PTH.

An elevated PTH in the setting of hypercalcemia indicates primary hyperparathyroidism, as PTH is autonomously secreted and driving the calcium up while wasting phosphate.

2

Evaluate the second profile (Calcium: 7.6, Phosphate: 5.8, PTH: 250).

The patient has hypocalcemia, hyperphosphatemia, and markedly elevated PTH.

Hyperphosphatemia binds calcium leading to hypocalcemia, which strongly stimulates PTH release. This is the classic pattern of secondary hyperparathyroidism seen in chronic kidney disease due to failure to excrete phosphate.

3

Evaluate the third profile (Calcium: 7.5, Phosphate: 5.2, PTH: 8).

The patient has hypocalcemia, hyperphosphatemia, and low PTH.

A low PTH in the setting of hypocalcemia points to an inability of the parathyroid glands to produce hormone (hypoparathyroidism), leading to lack of calcium reabsorption and lack of phosphate excretion.

4

Evaluate the fourth profile (Calcium: 8.0, Phosphate: 2.2, PTH: 140).

The patient has hypocalcemia, hypophosphatemia, and elevated PTH.

Poor absorption of calcium and phosphate from the gut characterizes vitamin D deficiency. The resulting hypocalcemia appropriately stimulates PTH, which normalizes calcium slightly but causes further renal wasting of phosphate.

Key Concept

Differentiating disorders of calcium and phosphate metabolism using intact PTH levels.

Estimated Time:1m 30s

Question 3746Question →

Match each clinical scenario of acquired antineoplastic drug resistance with the specific foundational molecular mechanism driving the neoplastic progression.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Colorectal cancer on panitumumab matches with downstream effector mutation; NSCLC T790M matches with steric hindrance and increased ATP affinity; Breast cancer ESR1 matches with ligand-independent activation; CML T315I matches with loss of a critical hydrogen bond.

The correct pairings accurately reflect the specific molecular evolutionary strategies tumors use to evade targeted therapies, distinguishing between downstream pathway activation, physical receptor alterations, and functional changes to transcription factors.

Step-by-Step Solution

1

Analyze the mechanism of panitumumab resistance in colorectal cancer.

Matched to clonal expansion of a downstream effector mutation.

Panitumumab is an anti-EGFR antibody. Tumors escape this blockade by mutating downstream cascade proteins (like KRAS), making the upstream receptor inhibition irrelevant.

2

Analyze the mechanism of erlotinib resistance via the T790M mutation.

Matched to steric hindrance and increased ATP affinity.

T790M is the classic 'gatekeeper' mutation in EGFR that physically blocks the binding of first-generation reversible TKIs due to the bulky methionine residue.

3

Analyze the mechanism of aromatase inhibitor resistance via ESR1 mutation.

Matched to ligand-independent transcription factor activation.

Since aromatase inhibitors deprive the tumor of estrogen, the tumor evolves by acquiring ESR1 mutations that allow the estrogen receptor to function without its ligand.

4

Analyze the mechanism of imatinib resistance via the T315I mutation.

Matched to the elimination of a critical hydrogen bond.

In BCR-ABL, threonine 315 forms a vital hydrogen bond with imatinib. Substituting it with isoleucine (T315I) breaks this bond, leading to profound drug resistance.

Key Concept

Molecular Mechanisms of Acquired Antineoplastic Drug Resistance

Question 3747Question →

A 55-year-old man presents to the transplant clinic with a 3-day history of fatigue, dark urine, and low-grade fever. He underwent an orthotopic liver transplant 8 weeks ago for alcohol-associated cirrhosis. His current immunosuppressive regimen includes tacrolimus, mycophenolate mofetil, and prednisone. His temperature is 38.1°C (100.6°F), blood pressure is 130/80 mmHg, and heart rate is 90/min. Physical examination reveals scleral icterus and mild right upper quadrant tenderness. Laboratory tests show significantly elevated aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and total bilirubin compared to his baseline from two weeks ago. Tacrolimus trough levels are within the target therapeutic range. The physician suspects acute cellular rejection. Arrange the following diagnostic and therapeutic steps in the most appropriate sequential order for evaluating and managing this patient's presentation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing suspected acute cellular rejection in a liver transplant recipient is to first perform hepatic Doppler ultrasonography, followed by a percutaneous liver biopsy, then administration of high-dose intravenous methylprednisolone, and finally administration of anti-thymocyte globulin if refractory.

In evaluating acute graft dysfunction after a liver transplant, the initial step must rule out vascular and biliary complications using hepatic Doppler ultrasonography. Once these mechanical issues are excluded, a liver biopsy is necessary to definitively diagnose acute cellular rejection (characterized histologically by portal inflammation, bile duct injury, and endotheliitis) and to rule out opportunistic infections (such as cytomegalovirus) or drug toxicity. After acute cellular rejection is histologically confirmed, the standard first-line treatment is high-dose intravenous corticosteroids. Finally, for the subset of patients who do not respond to initial corticosteroid therapy (steroid-refractory rejection), therapy is escalated to T-cell depleting agents such as anti-thymocyte globulin.

Step-by-Step Solution

1

Rule out structural and vascular complications

Hepatic Doppler ultrasound evaluates the graft vasculature and biliary trees.

Hepatic artery thrombosis or biliary leaks can rapidly lead to graft loss and require immediate surgical or endoscopic intervention rather than immunosuppression.

2

Confirm the diagnosis histologically

Percutaneous liver biopsy differentiates rejection from infection.

Empiric treatment with high-dose steroids without a biopsy can be dangerous if the true cause of graft dysfunction is an opportunistic infection (e.g., cytomegalovirus hepatitis) or recurrent disease.

3

Initiate first-line anti-rejection therapy

Intravenous methylprednisolone pulse therapy is administered.

Corticosteroids blunt the immune inflammatory cascade and are highly effective for most episodes of acute cellular rejection.

4

Escalate to second-line therapy if necessary

Anti-thymocyte globulin is given if the patient does not clinically or biochemically improve.

This agent is used for steroid-refractory rejection to aggressively deplete the T-lymphocytes that are mediating the graft destruction.

Key Concept

Sequential management of suspected acute cellular rejection in a liver transplant recipient

Question 3748Question →

During a preoperative medical history evaluation, it is critical to explicitly inquire about the use of over-the-counter dietary and herbal supplements. Patients frequently omit these substances from their medication lists unless directly prompted, despite their potential to cause significant systemic and perioperative complications. Match each herbal supplement below to the clinical complication most likely to be established if the patient continues its use immediately prior to undergoing surgery.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Ginkgo biloba matches with increased risk of perioperative hemorrhage; Kava extract matches with severe hepatotoxicity; Yohimbine matches with hypertensive crisis; Valerian root matches with prolonged emergence from anesthesia.

Each supplement possesses a distinct pharmacologic profile that dictates its specific perioperative risk. Ginkgo biloba causes bleeding via platelet inhibition. Kava extract is directly toxic to the liver. Yohimbine acts as a stimulant by antagonizing alpha-2 receptors, leading to catecholamine excess. Valerian root acts as a central nervous system depressant by potentiating GABAergic pathways.

Step-by-Step Solution

1

Evaluate the pharmacologic mechanism of Ginkgo biloba in a surgical context.

Identified as an inhibitor of platelet-activating factor.

To determine its direct impact on surgical hemostasis and bleeding risk.

2

Evaluate the toxicity profile of Kava extract.

Identified as a known hepatotoxin.

To assess the risk of metabolic compromise or acute organ failure.

3

Evaluate the receptor activity of Yohimbine.

Identified as an alpha-2 adrenergic antagonist.

To anticipate significant cardiovascular and sympathetic derangements.

4

Evaluate the central nervous system effects of Valerian root.

Identified as a GABAergic potentiator.

To determine its potential synergistic interaction with sedative and anesthetic agents.

Key Concept

Thorough preoperative medical history evaluation must include specific inquiries about herbal supplements to anticipate and prevent adverse intraoperative and postoperative events based on their distinct pharmacologic mechanisms.

Question 3749Question →

A clinical team is evaluating four different patients presenting with new-onset ascites. Diagnostic paracentesis is performed for each patient. Match the following serum and ascitic fluid laboratory profiles to the most likely underlying etiology.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Patient A matches Uncomplicated hepatic cirrhosis; Patient B matches Right-sided heart failure; Patient C matches Peritoneal carcinomatosis; Patient D matches Spontaneous bacterial peritonitis.

The precise diagnostic categorization of ascites relies on a three-step interpretation of laboratory fluid data. First, the SAAG (Serum Albumin minus Ascitic Albumin) determines if portal hypertension is present (

\geq 1.1 \text{ g/dL}

) or absent (

< 1.1 \text{ g/dL}

). Second, in the setting of portal hypertension, the ascitic total protein distinguishes sinusoidal (

\leq 2.5 \text{ g/dL}

, cirrhosis) from post-sinusoidal (

\geq 2.5 \text{ g/dL}

, right heart failure or constrictive pericarditis) etiologies. Third, regardless of the underlying cause, a PMN count

\geq 250 \text{ cells/}\mu\text{L}

independently establishes the superimposed diagnosis of spontaneous bacterial peritonitis.

Step-by-Step Solution

1

Calculate the Serum-Ascites Albumin Gradient (SAAG) for each patient by subtracting ascitic albumin from serum albumin.

Patient A =

2.0

; Patient B =

2.1

; Patient C =

0.8

; Patient D =

1.8

.

SAAG differentiates ascites caused by portal hypertension (

\geq 1.1 \text{ g/dL}

) from non-portal hypertension causes (

< 1.1 \text{ g/dL}

).

2

Evaluate the ascitic fluid total protein level for patients with portal hypertension (SAAG

\geq 1.1

).

Patient A (

1.5 \text{ g/dL}

) and Patient D (

1.8 \text{ g/dL}

) have low protein. Patient B (

3.1 \text{ g/dL}

) has high protein.

Ascitic total protein

\geq 2.5 \text{ g/dL}

indicates post-sinusoidal portal hypertension (e.g., heart failure), whereas

< 2.5 \text{ g/dL}

indicates sinusoidal portal hypertension (e.g., cirrhosis).

3

Analyze the absolute polymorphonuclear (PMN) leukocyte count in the ascitic fluid for all patients.

Only Patient D has a PMN count

\geq 250 \text{ cells/}\mu\text{L}

(

540 \text{ cells/}\mu\text{L}

).

An ascitic fluid PMN count

\geq 250 \text{ cells/}\mu\text{L}

is the diagnostic criterion for spontaneous bacterial peritonitis (SBP), which can complicate pre-existing cirrhotic ascites.

Key Concept

Ascitic fluid analysis algorithms using SAAG, total protein, and PMN cell counts to determine the etiology of ascites.

Question 3750Question →

A $24$ -year-old man is hospitalized for the treatment of newly diagnosed Burkitt lymphoma. He has a massive retroperitoneal tumor burden. Yesterday, he received his first cycle of systemic combination chemotherapy. Over the past $8$ hours, his urine output has decreased to approximately $15 \text{ mL/hr}$ . He reports mild nausea but denies muscle cramps, perioral numbness, or palpitations. Vital signs are stable. An electrocardiogram demonstrates a normal sinus rhythm with no PR or QT interval prolongation and normal T waves.

Laboratory evaluation reveals:
Potassium: $6.2 \text{ mEq/L}$
Uric acid: $14.8 \text{ mg/dL}$
Calcium: $6.2 \text{ mg/dL}$
Phosphorus: $9.5 \text{ mg/dL}$
Blood urea nitrogen: $45 \text{ mg/dL}$
Creatinine: $2.9 \text{ mg/dL}$ (baseline $0.9 \text{ mg/dL}$ )

Based on the cellular consequences of this rapid neoplastic destruction, which of the following is the most appropriate next step in the management of this patient?

Initiation of aggressive intravenous fluid hydration and administration of rasburicase

Intravenous infusion of calcium gluconate to rapidly correct the measured hypocalcemia

Immediate placement of a hemodialysis catheter for emergent renal replacement therapy

Non-contrast computed tomography of the abdomen and pelvis to rule out ureteral obstruction

Initiation of oral allopurinol and implementation of a strict low-purine diet

Show answer & explanation

Answer: Initiation of aggressive intravenous fluid hydration and administration of rasburicase

Answer

The most appropriate next step is the initiation of aggressive intravenous fluid hydration and administration of rasburicase.

This patient is presenting with severe Tumor Lysis Syndrome (TLS) following the initiation of chemotherapy for a highly proliferative neoplastic process. The massive destruction of tumor cells releases large amounts of intracellular potassium, phosphorus, and nucleic acids into the systemic circulation. The nucleic acids are rapidly catabolized to uric acid, which, along with calcium phosphate, precipitates in the renal tubules and causes acute kidney injury. The most critical next step is aggressive intravenous hydration to maintain a high urine flow rate and the administration of rasburicase. Rasburicase is a recombinant urate oxidase enzyme that rapidly catalyzes the oxidation of uric acid into allantoin, a highly water-soluble compound, thereby quickly clearing the uric acid burden and preventing further renal tubular crystallization.

Step-by-Step Solution

1

Identify the clinical syndrome based on the patient's history and laboratory values.

The patient has a highly proliferative neoplasm (Burkitt lymphoma) and developed hyperkalemia, hyperuricemia, hyperphosphatemia, and hypocalcemia shortly after chemotherapy, which is diagnostic for Tumor Lysis Syndrome (TLS).

Recognizing TLS is crucial for initiating condition-specific emergency management.

2

Connect the neoplastic process to the pathophysiology of the acute renal failure.

Massive chemotherapy-induced lysis of neoplastic cells releases intracellular ions and nucleic acids, leading to precipitation of uric acid and calcium phosphate crystals in the renal tubules.

Understanding that the renal failure is intrinsic (tubular precipitation) rather than obstructive dictates the medical approach.

3

Select the optimal medical intervention to reverse the pathophysiologic cascade.

Aggressive intravenous hydration is required to flush the tubules, and rasburicase is needed to rapidly degrade existing uric acid.

Rasburicase acts rapidly to clear the massive existing uric acid burden, unlike preventive agents like allopurinol.

Key Concept

Management of Tumor Lysis Syndrome and contraindications for treating asymptomatic hypocalcemia in the setting of hyperphosphatemia.

Estimated Time:1m 15s

Question 3751Question →

A surgical resident is urgently called to the bedside of a patient who underwent an uncomplicated total thyroidectomy 24 hours prior. The patient is complaining of acute-onset perioral numbness and tingling in the fingertips. The resident suspects a common postoperative metabolic complication related to inadvertent parathyroid gland injury or ischemia. If this clinical suspicion is correct, which of the following physical examination findings are most likely to be elicited in this patient? (Select all that apply)

Select all that apply

Induction of carpal spasm by inflating a sphygmomanometer cuff above the systolic blood pressure for 3 minutes

Twitching of the ipsilateral facial muscles when tapping over the facial nerve anterior to the ear

Delayed relaxation phase of the ankle jerk deep tendon reflex

Diffuse flaccid muscle weakness with depressed deep tendon reflexes

Rapid, irregular flapping tremors upon sustained extension of the wrists

Show answer & explanation

Answer: Induction of carpal spasm by inflating a sphygmomanometer cuff above the systolic blood pressure for 3 minutes; Twitching of the ipsilateral facial muscles when tapping over the facial nerve anterior to the ear

Answer

The correct findings are the induction of carpal spasm by inflating a blood pressure cuff (Trousseau sign) and twitching of the ipsilateral facial muscles upon tapping the facial nerve (Chvostek sign).

The clinical vignette describes a classic presentation of post-surgical hypoparathyroidism, a well-known complication of total thyroidectomy. The resulting acute hypocalcemia causes increased neuromuscular excitability. On physical examination, this is classically elicited by two provocative tests: the Trousseau sign (carpal spasm triggered by inflating a sphygmomanometer above the systolic pressure for 3 minutes, which induces local ischemia and exacerbates the irritability of the peripheral nerves) and the Chvostek sign (contraction of the ipsilateral facial muscles when the facial nerve is tapped just anterior to the ear).

Step-by-Step Solution

1

Identify the underlying clinical syndrome based on the patient's surgical history and acute symptoms.

The patient's perioral numbness and fingertip tingling 24 hours post-thyroidectomy indicate acute hypocalcemia resulting from transient or permanent hypoparathyroidism.

The parathyroid glands are anatomically adjacent to the thyroid and share a blood supply, making them highly susceptible to inadvertent injury, removal, or ischemia during thyroid surgery.

2

Determine the expected physical examination findings that correlate with this acute metabolic derangement.

Acute hypocalcemia lowers the threshold potential for voltage-gated sodium channels, causing neuromuscular irritability and tetany, classically demonstrated by Trousseau sign and Chvostek sign.

These provocative maneuvers physically demonstrate the heightened neuronal excitability characteristic of low extracellular ionized calcium.

Key Concept

Hypocalcemia typically presents with neuromuscular irritability (tetany), clinically demonstrable via Trousseau sign and Chvostek sign, and is a classic complication following thyroidectomy.

Estimated Time:1m 30s

Question 3752Question →

A $35$ -year-old woman comes to the clinic for a routine wellness examination. She has no symptoms and feels entirely well. She has no significant past medical history and takes no medications other than an oral contraceptive pill. Her family history is notable for a father who underwent an unsuccessful neck surgery for hypercalcemia of unclear etiology in his twenties. Her vital signs are within normal limits, and the physical examination is unremarkable. Routine comprehensive metabolic panel reveals a serum calcium level of $11.2\text{ mg/dL}$ (normal: $8.4\text{ - }10.2\text{ mg/dL}$ ) and an albumin level of $4.0\text{ g/dL}$ (normal: $3.5\text{ - }5.0\text{ g/dL}$ ). A repeat laboratory draw one week later confirms a serum calcium of $11.1\text{ mg/dL}$ . A subsequent intact parathyroid hormone (PTH) level is $78\text{ pg/mL}$ (normal: $10\text{ - }65\text{ pg/mL}$ ) and $25$ -hydroxyvitamin D level is $32\text{ ng/mL}$ (normal: $20\text{ - }50\text{ ng/mL}$ ). Her serum creatinine is $0.8\text{ mg/dL}$ . Which of the following is the most appropriate next step in laboratory evaluation?

Genetic sequence analysis of the calcium-sensing receptor (CaSR) gene

Serum 1,25-dihydroxyvitamin D concentration

Measurement of 24-hour urinary calcium and creatinine excretion

Serum parathyroid hormone-related peptide (PTHrP) concentration

Serum ionized calcium concentration

Show answer & explanation

Answer: Measurement of 24-hour urinary calcium and creatinine excretion

Answer

Measurement of 24-hour urinary calcium and creatinine excretion

The correct answer is measurement of 24-hour urinary calcium and creatinine excretion. This patient presents with PTH-dependent hypercalcemia (elevated serum calcium with an inappropriately elevated intact PTH). The primary differential diagnosis is between primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcemia (FHH). FHH is an autosomal dominant condition caused by an inactivating mutation in the calcium-sensing receptor (CaSR) in the parathyroid glands and kidneys, leading to higher set-points for calcium homeostasis. A major clinical clue in this vignette is the father's history of 'unsuccessful neck surgery for hypercalcemia,' which is classic for FHH because subtotal parathyroidectomy does not correct the hypercalcemia. The crucial next step in laboratory evaluation is a 24-hour urine collection to calculate the calcium-to-creatinine clearance ratio (CCCR). A CCCR

< 0.01

strongly suggests FHH, while a ratio

> 0.02

indicates PHPT. Establishing this diagnosis biochemically is vital to prevent unnecessary surgical intervention.

Step-by-Step Solution

1

Interpret the initial laboratory findings.

The patient has true hypercalcemia (normal albumin) with an inappropriately elevated intact PTH, indicating PTH-dependent hypercalcemia.

This narrows the differential diagnosis down to primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcemia (FHH).

2

Analyze the family history.

The father had an 'unsuccessful neck surgery for hypercalcemia', which strongly points toward FHH, as parathyroidectomy is ineffective for this condition.

FHH is an autosomal dominant disorder that mimics the biochemical profile of PHPT but has a completely different management strategy.

3

Determine the next diagnostic test in the algorithm.

A 24-hour urine collection to calculate the calcium-to-creatinine clearance ratio (CCCR) is required.

A CCCR less than 0.01 suggests FHH, preventing unnecessary and ineffective parathyroid surgery, whereas a ratio greater than 0.02 suggests PHPT.

Key Concept

Differentiating primary hyperparathyroidism from familial hypocalciuric hypercalcemia (FHH) using the 24-hour urinary calcium-to-creatinine clearance ratio.

Question 3753Question →

A 60-year-old woman is evaluated in the hospital for decreased urine output on her third day of admission for severe gastroenteritis. Her vital signs show a blood pressure of 90/60 mm Hg and a heart rate of 110/min. Physical examination reveals dry mucous membranes and poor skin turgor. Laboratory studies are obtained to determine the etiology of her acute kidney injury:

Laboratory Test	Value
Plasma sodium	$140 \text{ mEq/L}$
Plasma creatinine	$2.0 \text{ mg/dL}$
Urine sodium	$14 \text{ mEq/L}$
Urine creatinine	$100 \text{ mg/dL}$

Based on the laboratory results provided, what is the patient's fractional excretion of sodium (FENa) expressed as a percentage?

Show answer & explanation

Answer: 0.2

Answer

0.2

The correct calculation yields a fractional excretion of sodium (FENa) of

0.2\%

. FENa measures the percentage of filtered sodium that is excreted in the urine. It is calculated as the ratio of sodium clearance to creatinine clearance. In this patient with a history of severe gastroenteritis, hypotension, and signs of volume depletion, a FENa of less than

1\%

is highly indicative of a prerenal state. The kidneys appropriately reabsorb sodium in response to decreased renal perfusion to restore intravascular volume.

Step-by-Step Solution

1

Identify the relevant diagnostic formula

\text{FENa} = \frac{\text{Urine Na} \times \text{Plasma Cr}}{\text{Plasma Na} \times \text{Urine Cr}} \times 100

To evaluate whether the acute kidney injury is prerenal or intrinsic.

2

Substitute the patient's laboratory values

\text{FENa} = \frac{14 \times 2.0}{140 \times 100} \times 100

Applying the specific plasma and urine values from the vignette.

3

Perform the arithmetic calculation

\frac{28}{14000} \times 100 = 0.002 \times 100 = 0.2

To yield the final percentage value for interpretation.

Key Concept

Calculating the fractional excretion of sodium (FENa) is a crucial step in evaluating acute kidney injury to distinguish between a prerenal etiology (FENa < 1%) and intrinsic renal pathology, such as acute tubular necrosis (FENa > 2%).

Question 3754Question →

Match each patient's presenting laboratory profile with the most likely underlying pathophysiological diagnosis. All patients present with a primary hypokalemic metabolic alkalosis and a normal serum creatinine level.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The normotensive patient with low urine chloride matches Covert emesis. The hypertensive patient matches Primary hyperaldosteronism. Between the two normotensive salt-wasters, the patient with hypocalciuria matches Gitelman syndrome, and the patient with hypercalciuria matches Bartter syndrome.

The correct matches require a systematic, multi-step interpretation of the laboratory panels. First, blood pressure divides the etiologies: hypertension suggests mineralocorticoid excess, isolating primary hyperaldosteronism. Next, urine chloride separates volume-contracted states attempting to intensely conserve chloride (covert emesis,

< 20

mEq/L) from renal salt-wasting states (

> 20

mEq/L). Finally, urine calcium effectively differentiates the remaining tubulopathies: Bartter syndrome causes hypercalciuria (like loop diuretics), whereas Gitelman syndrome causes hypocalciuria (like thiazide diuretics).

Step-by-Step Solution

1

Analyze blood pressure to categorize the etiologies of hypokalemic metabolic alkalosis.

Three patients are normotensive/hypotensive; one patient is severely hypertensive.

Hypertension isolated mineralocorticoid excess states (like primary hyperaldosteronism) from volume-contracted states or tubulopathies.

2

Evaluate urine chloride in the normotensive patients.

One patient has a urine

Cl^-

of 8 mEq/L; the other two have urine

Cl^-

> 60 mEq/L.

Urine chloride differentiates extrarenal chloride loss/volume depletion (saline-responsive,

< 20

mEq/L) from intrinsic renal salt-wasting defects (saline-resistant,

> 20

mEq/L).

3

Differentiate the two saline-resistant normotensive tubulopathies using the urine calcium-to-creatinine ratio.

One patient has profound hypocalciuria (ratio 0.02); the other has hypercalciuria (ratio 0.28).

Gitelman syndrome (DCT defect) mimics thiazides by increasing calcium reabsorption. Bartter syndrome (TAL defect) mimics loop diuretics by wasting calcium.

Key Concept

Algorithm for evaluating hypokalemic metabolic alkalosis using blood pressure, urine chloride, and urine calcium.

Estimated Time:2m 30s

Question 3755Question →

A 72-year-old man is brought to the emergency department by his daughter due to progressive lethargy and mild confusion over the past 48 hours. He has a history of essential hypertension treated with amlodipine. Physical examination reveals a blood pressure of 128/78 mmHg and a heart rate of 76/min. He appears euvolemic with moist mucous membranes, flat neck veins, and no peripheral edema. Initial laboratory studies show a serum sodium level of 122 mEq/L, potassium of 4.1 mEq/L, blood urea nitrogen of 10 mg/dL, and creatinine of 0.8 mg/dL. Arrange the following diagnostic laboratory tests in the most appropriate logical sequence to accurately deduce the underlying etiology of this patient's hyponatremia.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct logical sequence for evaluating hyponatremia is: Serum osmolality, followed by Urine osmolality, followed by Urine sodium concentration, and finally Thyroid and Adrenal function tests.

The standard diagnostic algorithm for hyponatremia follows a strict physiologic sequence to prevent misdiagnosis. It begins with confirming true hypotonicity, assesses the appropriate suppression of ADH, evaluates the effective arterial volume, and finally excludes mimicking endocrinopathies before settling on a diagnosis of SIADH.

Step-by-Step Solution

1

Determine serum tonicity.

Measurement of serum osmolality.

Differentiates true hypotonic hyponatremia from pseudohyponatremia (due to hyperlipidemia/hyperproteinemia) or hypertonic hyponatremia (due to osmotically active solutes like glucose).

2

Assess antidiuretic hormone (ADH) activity.

Measurement of urine osmolality.

Determines if the kidneys are appropriately diluting the urine (Uosm < 100 mOsm/kg, seen in primary polydipsia) or if ADH is inappropriately retaining free water (Uosm > 100 mOsm/kg).

3

Assess volume status and renal sodium handling.

Measurement of urine sodium concentration.

Differentiates hypovolemic states where the kidneys conserve sodium (UNa < 30 mEq/L) from euvolemic states like SIADH where sodium excretion is high (UNa > 30 mEq/L) due to relative volume expansion.

4

Rule out secondary endocrinopathies.

Measurement of serum TSH and morning cortisol.

SIADH is definitively a diagnosis of exclusion; hypothyroidism and adrenal insufficiency can both present with euvolemic hyponatremia and must be excluded prior to diagnosis.

Key Concept

The diagnostic algorithm for hyponatremia requires a strict sequential evaluation of serum tonicity, ADH activity (via urine osmolality), and volume status (via urine sodium), before ruling out specific endocrine causes.

Question 3756Question →

Match each patient's clinical presentation with the most appropriate targeted laboratory test or diagnostic panel to order next.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct diagnostic laboratory workups are matched to their respective clinical syndromes: Dermatomyositis (muscle enzymes and anti-Jo-1), Multiple Myeloma (protein electrophoresis and free light chains), Pheochromocytoma (metanephrines), and Chronic Myeloid Leukemia (BCR-ABL1 testing).

Each clinical vignette contains highly specific pathognomonic clues that correlate directly with a singular definitive diagnostic or screening laboratory pathway. Accurate pattern recognition dictates these specific evidence-based laboratory orders.

Step-by-Step Solution

1

Analyze the 42-year-old woman's symptoms (Gottron papules, heliotrope rash, proximal weakness).

Identified as dermatomyositis.

Indicates a need for myositis-specific antibodies and muscle enzymes to confirm muscle inflammation and autoimmune etiology.

2

Recognize the 68-year-old man's combination of hypercalcemia, renal failure, anemia, and bone pain.

Identified as highly suspicious for multiple myeloma.

Requires monoclonal protein testing via serum/urine electrophoresis and free light chains to establish the diagnosis of a plasma cell dyscrasia.

3

Evaluate the 34-year-old woman's episodic symptom triad with resistant hypertension.

Identified as classic for pheochromocytoma.

Prompts initial biochemical screening with plasma or 24-hour urine metanephrines prior to any localization imaging.

4

Assess the 55-year-old man's massive splenomegaly and marked leukocytosis with full maturation spectrum.

Identified as chronic myeloid leukemia (CML).

Requires definitive molecular confirmation by testing for the BCR-ABL1 fusion gene transcript.

Key Concept

Cost-effective and accurate patient management requires recognizing classic clinical syndromes and ordering the single most specific initial diagnostic laboratory test or panel, avoiding non-directed shotgun testing.

Question 3757Question →

A 55-year-old woman undergoes a routine screening mammogram that demonstrates a new, irregularly shaped, spiculated mass in the upper outer quadrant of her left breast. Arrange the following diagnostic modalities in the most appropriate chronological sequence for her subsequent workup and management.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for evaluating a suspicious mass found on a screening mammogram is: Diagnostic mammography with specialized views, followed by Targeted ultrasonography of the affected breast, then Image-guided core needle biopsy, and finally Contrast-enhanced magnetic resonance imaging (MRI) of the breasts.

The standard diagnostic pathway for a suspicious breast lesion starts with complete imaging characterization. Screening mammograms must be followed by diagnostic mammograms to clearly define margins and calcifications. Targeted ultrasound then distinguishes cystic from solid components and evaluates the axilla. Once imaging confirms a suspicious solid mass, an image-guided core needle biopsy provides the definitive histologic diagnosis. Finally, breast MRI is often reserved for preoperative staging after cancer is confirmed to accurately map the extent of the disease.

Step-by-Step Solution

1

Select Diagnostic mammography with specialized views as the first step.

Diagnostic mammography is placed in the first position.

An abnormal screening mammogram requires further characterization with diagnostic views (e.g., spot compression) before any other imaging or intervention.

2

Select Targeted ultrasonography of the affected breast as the second step.

Targeted ultrasonography is placed in the second position.

Once the lesion is characterized mammographically, ultrasound is used to determine if it is a simple cyst or a solid mass, and to assess regional lymph nodes.

3

Select Image-guided core needle biopsy as the third step.

Image-guided core needle biopsy is placed in the third position.

A highly suspicious solid mass (BI-RADS 4 or 5) requires tissue sampling for a definitive histologic diagnosis before treatment planning.

4

Select Contrast-enhanced magnetic resonance imaging (MRI) of the breasts as the final step.

Contrast-enhanced MRI is placed in the fourth position.

Following a confirmed cancer diagnosis, MRI may be used for preoperative staging to evaluate disease extent and plan surgical margins.

Key Concept

Diagnostic sequencing for a suspicious breast mass identified on screening mammography involves progressively characterizing the lesion with imaging before proceeding to biopsy and preoperative staging.

Question 3758Question →

A $38$ -year-old man is brought to the emergency department by emergency medical services after being found lethargic and confused in his unheated garage during winter. Beside him was an unlabeled jug containing a brightly colored liquid. His blood pressure is $110/70$ mm Hg, pulse is $102$ /min, and respirations are $26$ /min and deep. Physical examination reveals a somnolent patient who localizes to painful stimuli. Cardiopulmonary examination is unremarkable, and he has no focal neurologic deficits. Laboratory results are as follows:

Laboratory Test	Result	Reference Range
Sodium	$142$ mEq/L	$136$ - $145$ mEq/L
Potassium	$5.0$ mEq/L	$3.5$ - $5.0$ mEq/L
Chloride	$104$ mEq/L	$95$ - $105$ mEq/L
Bicarbonate	$10$ mEq/L	$22$ - $28$ mEq/L
Blood urea nitrogen (BUN)	$14$ mg/dL	$7$ - $18$ mg/dL
Creatinine	$1.2$ mg/dL	$0.6$ - $1.2$ mg/dL
Glucose	$198$ mg/dL	$70$ - $110$ mg/dL
Measured serum osmolality	$332$ mOsm/kg H $_2$ O	$275$ - $295$ mOsm/kg H $_2$ O

Based on the provided laboratory results, calculate the patient's osmolar gap. Enter only the numerical value.

Show answer & explanation

Answer: 32

Answer

32

This patient presents with altered mental status and deep respirations (Kussmaul breathing) in the setting of wintertime exposure to a brightly colored, unlabelled fluid, raising strong suspicion for ethylene glycol (antifreeze) toxicity. The laboratory results show a high anion gap metabolic acidosis (Anion gap =

142 - (104 + 10) = 28

). To evaluate for the presence of toxic alcohols, an osmolar gap should be calculated. The formula for calculated serum osmolality is

2 \times [\text{Na}^+] + \frac{\text{Glucose}}{18} + \frac{\text{BUN}}{2.8}

. Using the patient's values, this yields

2(142) + \frac{198}{18} + \frac{14}{2.8} = 284 + 11 + 5 = 300

mOsm/kg. The osmolar gap is the measured osmolality minus the calculated osmolality (

332 - 300 = 32

mOsm/kg). A normal gap is typically

< 10

mOsm/kg; a gap of

32

strongly supports the presence of an unmeasured osmotically active substance, confirming the suspicion of toxic alcohol ingestion.

Step-by-Step Solution

1

Extract the relevant values required for the calculated osmolality formula.

Sodium =

142

, Glucose =

198

, BUN =

14

.

The calculated serum osmolality depends on the primary osmotic drivers in the serum.

2

Apply the calculated osmolality formula:

2 \times [\text{Na}^+] + \frac{\text{Glucose}}{18} + \frac{\text{BUN}}{2.8}

.

2 \times 142 + \frac{198}{18} + \frac{14}{2.8} = 284 + 11 + 5 = 300

mOsm/kg.

This formula estimates the total particle concentration normally present in the blood. The divisors convert mg/dL to mmol/L.

3

Calculate the osmolar gap by subtracting the calculated osmolality from the measured osmolality.

Osmolar gap =

332 - 300 = 32

mOsm/kg.

The difference between measured and calculated osmolality reveals the presence of unmeasured osmotically active substances (e.g., toxic alcohols).

Key Concept

Calculation of the osmolar gap is an essential step in diagnosing toxic alcohol ingestions (such as ethylene glycol or methanol) in patients presenting with altered mental status and a high anion gap metabolic acidosis.

Estimated Time:1m 30s

Question 3759Question →

For each of the following patients suspected of having a central nervous system infection, select the most appropriate targeted cerebrospinal fluid laboratory test to order next.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Patient 1 requires Cryptococcal antigen testing, Patient 2 requires HSV PCR, Patient 3 requires West Nile virus IgM, and Patient 4 requires Gram stain and culture.

Each patient's clinical scenario contains specific pathognomonic features or risk factors that dictate the most appropriate targeted CSF laboratory test. The advanced HIV patient with high intracranial pressure requires cryptococcal antigen testing; the patient with temporal lobe signs needs HSV PCR; the patient with late summer flaccid paralysis needs West Nile virus IgM; and the military recruit with a petechial rash requires Gram stain and bacterial culture.

Step-by-Step Solution

1

Analyze the first presentation: An immunocompromised patient with subacute headache and papilledema without meningeal signs.

Identified high suspicion for Cryptococcal meningoencephalitis.

Cryptococcus neoformans causes elevated intracranial pressure with minimal inflammation in advanced HIV, making cryptococcal antigen testing the most appropriate diagnostic test.

2

Analyze the second presentation: Acute onset of fever, altered mental status, and a seizure preceded by an olfactory aura.

Identified high suspicion for temporal lobe involvement, characteristic of HSV encephalitis.

HSV has a predilection for the temporal lobes, causing olfactory auras and seizures. The diagnostic test of choice is CSF HSV PCR.

3

Analyze the third presentation: Late summer meningoencephalitis accompanied by acute asymmetric flaccid paralysis.

Identified high suspicion for West Nile virus neuroinvasive disease.

West Nile virus targets anterior horn cells, leading to a polio-like flaccid paralysis. It is diagnosed via CSF West Nile virus IgM.

4

Analyze the fourth presentation: Young adult in crowded quarters with acute meningismus and a petechial rash.

Identified high suspicion for meningococcal meningitis.

Neisseria meningitidis is a leading cause of bacterial meningitis in military recruits and causes a characteristic petechial rash. CSF Gram stain and culture are required.

Key Concept

Selection of targeted cerebrospinal fluid laboratory tests based on distinct clinical presentations, host risk factors, and epidemiologic clues of central nervous system infections.

Question 3760Question →

Match each complex neurological or paraneoplastic clinical presentation with the most specific and appropriate targeted diagnostic laboratory test.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct pairings match the underlying syndrome to its specific diagnostic assay: Creutzfeldt-Jakob disease pairs with the RT-QuIC assay; Anti-NMDA receptor encephalitis pairs with anti-GluN1 receptor antibodies; Paraneoplastic cerebellar degeneration pairs with the anti-Hu/Yo/Ri panel; and Miller Fisher syndrome pairs with anti-GQ1b ganglioside testing.

Each clinical vignette presents a highly specific neurological autoimmune or rapidly progressive degenerative syndrome that corresponds uniquely to a specialized diagnostic laboratory test. Properly ordering these tests prevents diagnostic delay and premature closure in rare but critical conditions.

Step-by-Step Solution

1

Evaluate the presentation of the 62-year-old with rapidly progressive dementia and myoclonus.

Identifies highly suspected Creutzfeldt-Jakob disease.

The clinical triad combined with 1-Hz sharp wave complexes on EEG requires specific confirmation of prion disease via the RT-QuIC assay.

2

Analyze the 26-year-old with post-teratoma psychiatric symptoms and dyskinesias.

Identifies anti-NMDA receptor encephalitis.

Ovarian teratomas commonly trigger NMDA receptor autoantibodies, requiring specific cerebrospinal fluid testing for confirmation.

3

Assess the 68-year-old smoker with subacute cerebellar ataxia and a lung mass.

Identifies paraneoplastic cerebellar degeneration.

Suspected small cell lung cancer driving an autoimmune cerebellar process necessitates a paraneoplastic antibody panel (including anti-Hu).

4

Examine the 45-year-old with acute ophthalmoplegia, ataxia, and areflexia post-gastroenteritis.

Identifies Miller Fisher syndrome.

This specific clinical triad (without generalized weakness) is universally linked to anti-GQ1b antibodies, differentiating it from classic Guillain-Barré syndrome.

Key Concept

Targeted laboratory evaluation of rapidly progressive neurological and paraneoplastic syndromes based on highly specific clinical phenotypes.

Estimated Time:2m 0s

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Alternative Method

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution